THE PNPLA3 I148M VARIANT INITIATES METABOLIC REPROGRAMMING IN MACROPHAGES

被引：0
|
作者：
Dixon, Emmanuel [1 ]
Claudel, Thierry [1 ]
Genger, Jakob-Wendelin [1 ]
Zhu, Ci [1 ]
Stadlmayr, Sarah [1 ]
Paolini, Erika [2 ]
Nardo, Alexander [1 ]
Mlitz, Veronika [1 ]
Fuchs, Claudia [1 ]
Bergthaler, Andreas [1 ]
Dongiovanni, Paola [2 ]
Ellmeier, Wilfried [1 ]
Trauner, Michael [1 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Med Univ Milan, Milan, Italy
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2629
引用
收藏
页码：S1990 / S1991
页数：2
相关论文
共 50 条
  • [21] The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta-analysis
    Shen, Jian-Hua
    Li, Yi-Ling
    Li, Dan
    Wang, Ning-Ning
    Jing, Lei
    Huang, Yu-Hong
    JOURNAL OF LIPID RESEARCH, 2015, 56 (01) : 167 - 175
  • [22] Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant
    Jonsson, Cecilia
    Bergram, Martin
    Kechagias, Stergios
    Nasr, Patrik
    Ekstedt, Mattias
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2024, 59 (06) : 737 - 741
  • [23] The rs738409 (I148M) Variant of the PNPLA3 Gene and Type 2 Diabetes in Yakutia
    Sydykova, Lubov A.
    Kurtanov, Khariton A.
    Borisova, Natalia V.
    Pavlova, Nadejda I.
    Stepanov, Konstantin M.
    Markova, Sardana V.
    Makarov, Albert D.
    Alekseeva, Sardana N.
    Antipina, Uliana D.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2018, 8 (03) : 201 - 205
  • [24] The PNPLA3 I148M variant and chronic liver disease: When a genetic mutation meets nutrients
    Maglio, Cristina
    Pirazzi, Carlo
    Pujia, Arturo
    Valenti, Luca
    Romeo, Stefano
    FOOD RESEARCH INTERNATIONAL, 2014, 63 : 239 - 243
  • [25] PNPLA3 I148M Involved in Mechanism of Variability in Antilipogenesis Response to Exenatide
    Chen, Yunzhi
    Liang, Hua
    Xu, Fen
    DIABETES, 2020, 69
  • [26] PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review
    Boeckmans, Joost
    Gatzios, Alexandra
    Schattenberg, Joern M.
    Koek, Ger H.
    Rodrigues, Robim M.
    Vanhaecke, Tamara
    LIVER INTERNATIONAL, 2023, 43 (05) : 975 - 988
  • [27] Mutant PNPLA3 I148M Protein as Pharmacological Target for Liver Disease
    Valenti, Luca
    Dongiovanni, Paola
    HEPATOLOGY, 2017, 66 (04) : 1026 - 1028
  • [28] PNPLA3 I148M POLYMORPHISM, ETIOLOGY, AND CLINICAL FEATURES OF HEPATOCELLULAR CARCINOMA
    Valenti, Luca
    Motta, Benedetta M.
    Bertelli, Cristina
    Sangiovanni, Angelo
    Rametta, Raffaela
    Dongiovanni, Paola
    Colombo, Massimo
    Fargion, Silvia
    Fracanzani, Anna Ludovica
    HEPATOLOGY, 2011, 54 : 1292A - 1292A
  • [29] PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease
    Speliotes, Elizabeth K.
    Schneider, Carolin Victoria
    LIVER INTERNATIONAL, 2025, 45 (03)
  • [30] The PNPLA3 Variant Associated With Fatty Liver Disease (I148M) Accumulates on Lipid Droplets by Evading Ubiquitylation
    BasuRay, Soumik
    Smagris, Eriks
    Cohen, Jonathan C.
    Hobbs, Helen H.
    HEPATOLOGY, 2017, 66 (04) : 1111 - 1124
12345